Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Chinese Clinical Oncology|April 6, 2015
Chemotherapy, biochemotherapy and anti-VEGF therapy in metastatic mucosal melanomaChuanliang Cui, Bixia Tang, Jun Guo
Journal of Cancer Research and Therapeutics|July 16, 2021
The combination therapy with the cytotoxic T lymphocyte-associated antigen-4 and programmed death 1 antibody-induced asthma in a patient with advanced melanomaWeiran Xu, Bin Lian, Chuanliang Cui, et al.
Acta Oto-Laryngologica|December 27, 2021
Gene mutations and clinical prognosis of mucosal melanoma in different locations of head and neckWei Guo, Gaofei Yin, Chuanliang Cui, et al.
Journal of Translational Medicine|November 7, 2019
Correction to: Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapyLongwen Xu, Zhiyuan Cheng, Chuanliang Cui, et al.
European Radiology|May 25, 2026
Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanomaBinbin Jiang, Liqi Sun, Lu Si, et al.
Journal of Translational Medicine|July 31, 2019
Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapyLongwen Xu, Zhiyuan Cheng, Chuanliang Cui, et al.
Translational Oncology|October 31, 2020
Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology imagesJing Hu, Chuanliang Cui, Wenxian Yang, et al.
BMC Cancer|February 26, 2011
Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive casesZhihong Chi, Siming Li, Xinan Sheng, et al.
BMC Cancer|June 3, 2014
Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinomaSiming Li, Yan Kong, Lu Si, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2011
A randomised phase II trial of 1 month versus 1 year of adjuvant high-dose interferon α-2b in high-risk acral melanoma patientsLili Mao, Lu Si, Zhihong Chi, et al.
Pageof 13